Enable AccessibilityEnable Accessibility

Shire To Present At 33Rd Annual J.P. Morgan Healthcare Conference

January 6, 2015

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Flemming Ornskov, MD, Chief Executive Officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2015 at 3:00 p.m. PT (6:00 p.m. ET).

A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at .

Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.

For further information please contact:

Investor Relations  

Sarah Elton Farr 
[email protected]
+44 1256 894157


Stephanie Fagar 
[email protected]
+1 201 572 9581

Jessica Cotrone 
[email protected]
+1 781 482 9538


Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.


Click here for the PDF version of this press release.